RJA
STXS icon

Raymond James & Associates’s Stereotaxis STXS Stock Holding History

Raymond James & Associates’s Portfolio STXS Stock Details STXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$21.1K Hold
10,350
– – ﹤0.01% 3944
2024
Q2 		$18.8K Buy
+10,350
New +$23.2K ﹤0.01% 3894

Other funds holding STXS

DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APCM
Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Raymond James & Associates's STXS Position: Q3 2024 in Review

Raymond James & Associates held its Stereotaxis (STXS) position steady in Q3 2024 at 10,350 shares worth $21.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3944.

Raymond James & Associates first reported a position in STXS in Q2 2024 and has held it in 2 quarters since. 84 funds tracked by Wall St. Rank hold STXS as of Q3 2024.

  • Raymond James & Associates held 10,350 shares of Stereotaxis worth $21.1K as of Q3 2024.
  • Raymond James & Associates left its Stereotaxis share count unchanged in Q3 2024.
  • Stereotaxis made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3944 holding.
  • Raymond James & Associates first reported a position in Stereotaxis in Q2 2024 and has held it in 2 quarters since.
  • 84 funds tracked by Wall St. Rank held Stereotaxis as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.